Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
Titel:
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
Auteur:
Judson, Ian Verweij, Jaap Gelderblom, Hans Hartmann, Jörg T Schöffski, Patrick Blay, Jean-Yves Kerst, J Martijn Sufliarsky, Josef Whelan, Jeremy Hohenberger, Peter Krarup-Hansen, Anders Alcindor, Thierry Marreaud, Sandrine Litière, Saskia Hermans, Catherine Fisher, Cyril Hogendoorn, Pancras C W dei Tos, A Paolo van der Graaf, Winette T A